Cardlytics (CDLX) Stock Price, News & Analysis

Company Overview

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Key Stats

• Today's Range: $1.01 to $1.08
• 50-Day Range: $1.01 to $3.12
• 52-Week Range: $0.95 to $5.25
• Volume: 813,663 shs
• Average Volume: 1.50 million shs
• Market Capitalization: $54.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.25
• Consensus Rating: Moderate Buy

Cardlytics Stock Analysis - MarketRank™

Cardlytics scored higher than 75% of companies evaluated by MarketBeat, and ranked 87th out of 316 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Cardlytics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Cardlytics has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cardlytics is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cardlytics is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cardlytics has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.65% of the float of Cardlytics has been sold short.

Short Interest Ratio / Days to Cover

Cardlytics has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in Cardlytics has recently increased by 0.31%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cardlytics does not currently pay a dividend.

Dividend Growth

Cardlytics does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 2.8 / 5
• Environmental Score: -0.67

Percentage of Shares Shorted

12.65% of the float of Cardlytics has been sold short.

Short Interest Ratio / Days to Cover

Cardlytics has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in Cardlytics has recently increased by 0.31%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: N/A

News Sentiment

Cardlytics has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Cardlytics this week, compared to 5 articles on an average week.

Search Interest

3 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $187,768.00 in company stock.

Percentage Held by Insiders

Only 4.40% of the stock of Cardlytics is held by insiders.

Percentage Held by Institutions

68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CDLX Stock Analysis - Frequently Asked Questions

How have CDLX shares performed this year?

Cardlytics' stock was trading at $3.71 on January 1st, 2025. Since then, CDLX stock has decreased by 72.5% and is now trading at $1.02.

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) announced its earnings results on Wednesday, November, 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.33) by $0.18. The business's quarterly revenue was down 15.1% compared to the same quarter last year.
Read the conference call transcript.

Does Cardlytics have any subsidiaries?

The following companies are subsidiaries of Cardlytics: Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

When did Cardlytics IPO?

Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Who are Cardlytics' major shareholders?

Top institutional investors of Cardlytics include Lane Generational LLC (1.49%), Geode Capital Management LLC (1.20%), Acorn Financial Advisory Services Inc. ADV (0.62%) and Wolverine Asset Management LLC. Insiders that own company stock include Clifford Sosin, Amit Gupta, Karim Saad Temsamani, Scott D Grimes, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen and John V Balen.
View institutional ownership trends.

How do I buy shares of Cardlytics?

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 8/29/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:CDLX
• CIK: 1666071
• Web: www.cardlytics.com
• Phone: (888) 798-5802
• Fax: N/A
• Employees: 500
• Year Founded: 2008

Price Target and Rating

• Average Price Target for Cardlytics: $2.25
• High Price Target: $2.50
• Low Price Target: $2.00
• Potential Upside/Downside: +120.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$189.30 million
• Net Margins: -68.87%
• Pretax Margin: -68.87%
• Return on Equity: -279.39%
• Return on Assets: -48.17%

Debt

• Debt-to-Equity Ratio: 2.87
• Current Ratio: 1.16
• Quick Ratio: 1.16

Sales & Book Value

• Annual Sales: $278.30 million
• Price / Sales: 0.20
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.10 per share
• Price / Book: 0.93

Miscellaneous

• Outstanding Shares: 53,240,000
• Free Float: 50,895,000
• Market Cap: $54.30 million
• Optionable: Optionable
• Beta: 1.26